CompletedEarly Phase 1NCT04747847

Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease

Studying Kawasaki disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of California, San Diego
Principal Investigator
Adriana Tremoulet, MD
Professor
Intervention
Atorvastatin and anakinra(drug)
Enrollment
5 enrolled
Eligibility
1-17 years · All sexes
Timeline
2019 – 2022

Study locations (1)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04747847 on ClinicalTrials.gov

Other trials for Kawasaki disease

Additional recruiting or active studies for the same condition.

See all trials for Kawasaki disease →

← Back to all trials